Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    9:00 AM - 10:30 AM Central Time
    26S12: Management of Challenging Cases in Myositis
    Location: W183A-C
    Moderator: Jemima Albayda, MD, RhMSUS – Johns Hopkins University
    Moderator: Sangmee Bae, MD, MS – UCLA
    Session Coordinator: Julie Paik, MD, MHS – Johns Hopkins University
    Session Coordinator: David Fernandez, MD, PhD – Hospital for Special Surgery
     CE: 1.50
  • Sunday, Oct 26th
    9:00 AM - 9:30 AM Central Time
    Decoding Anti-Synthetase Syndrome
    Location: W183A-C
    Speaker: Rohit Aggarwal, MD, MS – University of Pittsburgh
  • Sunday, Oct 26th
    9:30 AM - 10:00 AM Central Time
    Immune-Mediated Necrotizing Myopathy
    Location: W183A-C
    Speaker: Eleni Tiniakou, MD – UT Health Science Houston
  • Sunday, Oct 26th
    10:00 AM - 10:30 AM Central Time
    Management of Recalcitrant Dermatomyositis
    Location: W183A-C
    Speaker: Alisa Femia, MD – NYU School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0280: Sera from dermatomyositis patients induce muscle weakness via activation of type I interferon (IFN) receptors.
    Location: Hall F1
    Abstract Poster Presenter: Daniel C. Andersson, MD;PhD (he/him/his) – Karolinska Institutet
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0281: anti-il-6 Autoantibodies and IL-6 Signalling in Idiopathic Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: Katja Perdan Pirkmajer, MD, PhD – University Medical Centre Ljubljana
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0282: Clinical Meaningfulness and Improvement Thresholds of Myositis Core Set Measures: Association with Patient-Reported Outcomes
    Location: Hall F1
    Abstract Poster Presenter: Raisa Lomanto Silva, MD (she/her/hers) – Massachusetts General Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0283: The Performance of Rule-Based Algorithms to Identify Patients With Idiopathic Inflammatory Myopathies in Electronic Health Records
    Location: Hall F1
    Abstract Poster Presenter: Ana Valle, MD, MHS – Brigham and Women's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0284: Glucocorticoid Tapering and Relapse Risk in Anti-ARS Antibody-Positive Myositis: A Retrospective Study in a Single-Center Cohort Treated with Immunosuppressants
    Location: Hall F1
    Abstract Poster Presenter: Ayaka Inoue, MD – Kakogawa Central City Hospital, Kakogawa, Japan.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0285: Delayed-Onset Myopathy in Dermatomyositis: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Connor Buechler, MD – University of Minnesota
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0286: Anifrolumab for Treatment of Refractory Juvenile Dermatomyositis in Adult Patients
    Location: Hall F1
    Abstract Poster Presenter: Connor Buechler, MD – University of Minnesota
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0287: Comprehensive Profiling of Neutrophil Subsets Reveals Functional Signatures Linked to Vasculopathic Features in Patients with Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: DANIEL CARRILLO VAZQUEZ, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0288: Predictors and Characteristics of Objective Flares in Adult Dermatomyositis
    Location: Hall F1
    Abstract Poster Presenter: Didem Saygin, MD – Rush University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0289: Standardized Interoperable Data Collection for Myositis Research: Developing Common Data Elements for Myositis Disease Activity Core Set Measures
    Location: Hall F1
    Abstract Poster Presenter: Didem Saygin, MD – Rush University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0290: Comparison of Organ Damage and Survival in Anti-synthetase Syndrome and Other Idiopathic Inflammatory Myopathies: An Analysis of Patients from Turkey
    Location: Hall F1
    Abstract Poster Presenter: Ezgi Sahin, n/a (she/her/hers) – Istanbul University Istanbul Faculty of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0291: Acute Onset Inflammatory Myositis: Clinical Features and Survival
    Location: Hall F1
    Abstract Poster Presenter: Gollakota Nandita, MBBS/MD – NIMS, Hyderabad
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0292: Patterns and Predictors of Longitudinal Trajectories of Pain in Individuals with Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: Haley Zimmerman, MD (she/her/hers) – Rush University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0293: Presence of Anti-cN-1A (Mup44, NT5c1A) IgG is Specific for Sporadic Inclusion Body Myositis
    Location: Hall F1
    Abstract Poster Presenter: Jackie Weiss, PhD – EUROIMMUN US
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0294: Clinical relevance of low titer positive myositis-specific autoantibodies and myositis-associated autoantibodies in patients with an underlying malignancy.
    Location: Hall F1
    Abstract Poster Presenter: Jocelyn Chow, MBBS (she/her/hers) – University of Ottawa
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0295: Multidimensional Analysis of Fatigue in Idiopathic Inflammatory Myopathies: Clinical, Psychological, and Sociodemographic Determinants
    Location: Hall F1
    Abstract Poster Presenter: Manali Sarkar, MBBS (she/her/hers) – Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra, India.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0296: Aggregation of HARS1 and Internalized Antibodies in Muscle Biopsies of Patients with Antisynthetase Syndrome and anti-jo1(hars) Autoantibodies
    Location: Hall F1
    Abstract Poster Presenter: Maria Casal-Dominguez, Staff Scientist – National Institutes of Health
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0297: Longitudinal Serum Proteomic Profiles – A Step Closer to Personalized Monitoring in Dermatomyositis
    Location: Hall F1
    Abstract Poster Presenter: Natasha Le Blanc, MD, BSc – McGill University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0298: Inter-rater Reliability of Hand-Held Dynamometry in Patients with Idiopathic Inflammatory Myopathy
    Location: Hall F1
    Abstract Poster Presenter: Niladri Bhowmick, DM – Yashoda Hospital, Hyderabad
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0299: Interpreting Myositis Autoantibody Line-Blot Immunoassays in Real-World Settings: Implications for Diagnostic Accuracy for Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: Pei-Hsinq Lai, MD – Taipei City Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0300: Exploring Malignancy in Anti-synthetase Syndrome: A Multisite Retrospective Study
    Location: Hall F1
    Abstract Poster Presenter: Reena Yaman, MD, MS, BSc (she/her/hers) – Mayo Clinic Florida
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0301: Novel HMGCS1 Deficiency Expands Proinflammatory Monocytes and Cytotoxic Populations with Increased Cytokine Release
    Location: Hall F1
    Abstract Poster Presenter: Sabrina Helmold Hait, PhD (she/her/hers) – NIAMS, NIH
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0302: Urine Kynurenine Pathway Biomarkers Correlate with Disease Activity and Damage Core Set Measures in JDM
    Location: Hall F1
    Abstract Poster Presenter: Shannon O'Connor, MD, PhD – Cincinnati Children's Hospital Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0303: A Predictive Model for Liver Enzyme Elevations Based on Creatine Kinase in Idiopathic Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: Shiri Keret, MD (she/her/hers) – Bnai Zion Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0304: Concordance for myositis-specific autoantibody detection between commercial enzyme-linked immunosorbent assay and line blot assay: a multi-center study across the Asia-Pacific region
    Location: Hall F1
    Abstract Poster Presenter: Takahisa Gono, MD – Nippon Medical School Graduate School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0305: From Movement to Meaning: Exploring Physical Function in IBM with Actigraphy
    Location: Hall F1
    Abstract Poster Presenter: Vaidehi Kothari, MBBS – University of Pittsburgh
  • Monday, Oct 27th
    10:00 AM - 11:30 AM Central Time
    27M20: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II: Basic & Translational Research
    Location: W190A-B
    Abstract Moderator: Iago Pinal-Fernandez, MD, PhD – NIAMS/National Institutes of Health
    Abstract Moderator: Vladimir Liarski, MD, MSc – University of Pittsburgh
     CE: 0.00
  • Monday, Oct 27th
    10:00 AM - 10:15 AM Central Time
    0861: Identification of Anti-HDGFL1 as a Novel Autoantibody in Seronegative Idiopathic Inflammatory Myopathies
    Location: W190A-B
    Presenting Author: Xueting Yuan, MD – Peking Union Medical College ;Beijing Chaoyang Hospital
  • Monday, Oct 27th
    10:15 AM - 10:30 AM Central Time
    0862: In immune-mediated necrotising myopathy, anti-HMGCR antibodies inhibit HMGCR activity, leading to the sarcoplasmic accumulation of lipid droplets and myofibres necrosis
    Location: W190A-B
    Presenting Author: Margherita Giannini, MD, PhD – Nouvel Hopital Civil, Strasbourg
  • Monday, Oct 27th
    10:30 AM - 10:45 AM Central Time
    0863: Myeloid Dendritic Cell Subsets Characterize Muscle of Inclusion Body Myositis Patients and Correlate with KLRG1+ and TBX21+ CD8+ T cells
    Location: W190A-B
    Presenting Author: Raphael Kirou, BSc – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
  • Monday, Oct 27th
    10:45 AM - 11:00 AM Central Time
    0864: Immunophenotyping Reveals Upregulated IL-9R on Circulating T and B Cells in Dermatomyositis
    Location: W190A-B
    Presenting Author: Danica Lee, BA – University of Pittsburgh School of Medicine
  • Monday, Oct 27th
    11:00 AM - 11:15 AM Central Time
    0865: Spatial Transcriptomic Analysis of Calcinosis Cutis in Dermatomyositis Uncovers Disease-Associated Pathways Involving IL-6, Tissue Remodeling, and Osteopontin
    Location: W190A-B
    Presenting Author: Cassie Parks, BA (they/she) – Johns Hopkins School of Medicine
  • Monday, Oct 27th
    11:15 AM - 11:30 AM Central Time
    0866: Immunoglobulin from sera of patients with myositis can passively enter cultured human endothelial cells
    Location: W190A-B
    Presenting Author: Sandra Ogbonnaya-Whittlesey, MD – NIH/NIAMS
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1191: Effect of ER Stress Inhibition With 4-Phenylbutyric Acid on Disease Phenotype in a Mouse Model of Myositis
    Location: Hall F1
    Abstract Poster Presenter: Alfredo Guzman, PhD (he/him/his) – Binghamton University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1192: Idiopathic Inflammatory Myopathies: A Prospective Phase 4 Controlled Trial Of Recombinant Herpes Zoster Vaccine
    Location: Hall F1
    Abstract Poster Presenter: ANA PAULA LUPPINO-ASSAD, MD, PhD – Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo (HC/FMUSP)
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1193: Lung Transplant Outcomes in Patients with Myositis- and Systemic Sclerosis-Associated Interstitial Lung Disease Compared to Idiopathic Pulmonary Fibrosis: A Multicentric Retrospective Analysis
    Location: Hall F1
    Abstract Poster Presenter: Angela Chang, MD – University of British Columbia
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1194: Risk of Calcinosis with Proton Pump Inhibitor Use in Adult Dermatomyositis and Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1195: Discordance between Immunoblot and ELISA in the detection of Jo-1 and Ro/Ro-52 Autoantibodies
    Location: Hall F1
    Abstract Poster Presenter: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1196: Prevalence of and Factors Associated with Chronic Opioid Use among Individuals with Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: Anuya Natu, MBBS – John H Stroger, Jr. Hospital of Cook County
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1197: Genetic Profiling of Idiopathic Inflammatory Myopathies in Indian Patients Reveals Genotype-Phenotype Correlation
    Location: Hall F1
    Abstract Poster Presenter: BANDANA JASSAL, MSc (she/her/hers) – ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1198: Induction of stable, GC-free remission in patients with severe, therapy-refractory anti-synthetase syndrome after using the bispecific CD19xCD3 T cell engager blinatumomab
    Location: Hall F1
    Abstract Poster Presenter: Christina Duesing, MD – Klinik f�r Rheumatologie
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1199: Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases (SARDs): Radiologic and Histologic Correlations
    Location: Hall F1
    Abstract Poster Presenter: Darya S. Jalaledin, MD – Université de Montréal
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1200: Mortality in Idiopathic Inflammatory Myopathy in the Toulouse cohort (MIIRTALITY)
    Location: Hall F1
    Abstract Poster Presenter: Gregory Pugnet, MD,PhD (he/him/his) – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1201: Prognostic Significance of 1-Year Pulmonary Function Changes in Myositis-Associated Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Irada Choudhuri, MD – University of Pittsburgh Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1202: High Prevalence of Asymptomatic Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: Validation of ACR/CHEST Risk Factors in a Hong Kong Cohort
    Location: Hall F1
    Abstract Poster Presenter: Iris Tang, MBBS, MRCP – Department of Medicine, LKS Faculty of Medicine, University of Hong Kong
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1203: Rituximab in Treatment Refractory vs Treatment Naive Anti Signal Recognition Particle (SRP) Myositis A Case Series
    Location: Hall F1
    Abstract Poster Presenter: ISRARUL HAQUE, MD, MBBS (he/him/his) – Institute of Post graduate Medical Education and Research, Kolkata
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1204: Validity and reliability of a new ultrasound-based semiquantitative echogenicity grading scale for myositis.
    Location: Hall F1
    Abstract Poster Presenter: Jemima Albayda, MD, RhMSUS – Johns Hopkins University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1205: Real-time MRI for assessment of swallowing impairment in inclusion body myositis and oculopharyngeal muscular dystrophy.
    Location: Hall F1
    Abstract Poster Presenter: Jens Schmidt, MD – Immanuel University Hospital Rüdersdorf, Brandenburg Medical School; Department of Neurology and Pain Therapy
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1206: Overexpression of lymphotoxin in autophagy-deficient mice as model for inclusion body myositis
    Location: Hall F1
    Abstract Poster Presenter: Jens Schmidt, MD – Immanuel University Hospital Rüdersdorf, Brandenburg Medical School; Department of Neurology and Pain Therapy
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1207: Cutaneous and Muscular Disease Trajectories in Adult Patients with Dermatomyositis
    Location: Hall F1
    Abstract Poster Presenter: Jesus Valencia, MD – Johns Hopkins Bayview Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1208: Neutrophil Activation in Juvenile Dermatomyositis: Associations with Muscle Function and Disease Progression
    Location: Hall F1
    Abstract Poster Presenter: Jia Shi, MD – University of Washington
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1209: Beyond Muscle Strength: Functional Performance Measures Enhance Assessment of Disease Activity in Juvenile Dermatomyositis
    Location: Hall F1
    Abstract Poster Presenter: Jia Shi, MD – University of Washington
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1210: Artificial Intelligence-based Capillaroscopy and Laboratory Biomarkers to Predict Disease Activity in Idiopathic Inflammatory Myopathies: Preliminary Data from the Capiami Cohort
    Location: Hall F1
    Abstract Poster Presenter: Jorge Álvarez-Troncoso, MD, PhD (MD, PhD) – Hospital Universitario La Paz
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1211: Plasma Levels of miR-133a-3p and miR-1-3p as Potential Biomarkers of Muscle Involvement and Initial Treatment Response in Myositis
    Location: Hall F1
    Abstract Poster Presenter: Kristina Svobodová, MD (she/her/hers) – Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1212: Relapse in Idiopathic Inflammatory Myopathies: insights from extended MyoCite and Italian Consortia
    Location: Hall F1
    Abstract Poster Presenter: Maria Rosa Pellico, MD – ASST Pini-CTO, Clinical Rheumatology Unit
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1213: Transitional Changes on High Resolution Computed Tomography (HRCT) in idiopathic inflammatory Myopathy- Associated Interstitial Lung Disease (IIM-ILD)
    Location: Hall F1
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1214: Association of paraoxonase1 Activity with Calcinosis in Patients with Scleroderma and Dermatomyositis : An Exploratory Analysis
    Location: Hall F1
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1215: Remission Rates and Predictors in Idiopathic Inflammatory Myopathy Subtypes: Insights from a Single-Center Cohort
    Location: Hall F1
    Abstract Poster Presenter: Sidra Tahir, MD, MBBS (she/her/hers) – University of Pittsburgh Medical Center, Mercy
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1216: Measurement Properties of a Shorter Health Assessment Questionnaire (HAQ-II) in Patients with Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: Sung-Ki Lee, MD – Rush Medical College
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1217: Validation and clincial use of anti-MDA5 test - LIA versus ELISA
    Location: Hall F1
    Abstract Poster Presenter: TING-YUAN LAN, MD – National Taiwan University Hospital Hsinchu Branch
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1218: Social Determinants Shape Health Outcomes in Idiopathic Inflammatory Myopathies: Insights from Lived Experience of 1,252 Patients
    Location: Hall F1
    Abstract Poster Presenter: Tsvetelina Velikova, MD, PhD, MPH (she/her/hers) – Sofia University St. Kliment Ohridski
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1219: anti-ro52 Antibody Identifies Patients with More Severe Lung Disease Among Patients with Idiopathic Inflammatory Myopathy
    Location: Hall F1
    Abstract Poster Presenter: Vasiliki Syrmou, MD, MSc – University General Hospital of Larissa
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1220: Predictors of Progressive Pulmonary Fibrosis in Idiopathic Inflammatory Myopathies : a Retrospective Study of 502 Cases
    Location: Hall F1
    Abstract Poster Presenter: Wei Bian, MD – Tianjin Medical University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2052: Prevalence of anti-neutrophil extracellular trap antibodies and their relationship with the clinical characteristics of patients with idiopathic inflammatory myopathies.
    Location: Hall F1
    Abstract Poster Presenter: AGUSTIN HERNANDEZ LOPEZ, II, MD (he/him/his) – INCMNSZ
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2053: A Prospective Study Unveils Damage Accrual and Myositis Specific Antibodies as Key Risk Factors for Mortality in Myositis
    Location: Hall F1
    Abstract Poster Presenter: AGUSTIN HERNANDEZ LOPEZ, II, MD (he/him/his) – INCMNSZ
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2054: A Changing Paradigm: Reassessing the Role of Muscle Biopsy in Idiopathic Inflammatory Myopathies in a Single-center Cohort
    Location: Hall F1
    Abstract Poster Presenter: Ami Purohit, MD – University of Miami
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2055: Construct Validity of Total Improvement Score (TIS) as an Endpoint for Clinically Meaningful Improvement in Multiple Patient-Centered Outcome Measures in Dermatomyositis
    Location: Hall F1
    Abstract Poster Presenter: Anjana Chandrasekhara Pillai, MD – PPCP
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2056: Systematic Review: Nutritional Interventions in Muscle Diseases
    Location: Hall F1
    Abstract Poster Presenter: Deepanjali Vedantam, MD, MBBS – Shasta Regional Medical Centre/Prime West Consortium
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2057: Clinical Associations of Anti-Ro52 Antibodies in Idiopathic Inflammatory Myopathies: A Scoping Review
    Location: Hall F1
    Abstract Poster Presenter: Emily Sun, MD, MPH – Royal Melbourne Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2058: Organ-specific disease activity and serological patterns in idiopathic inflammatory myopathies: A descriptive study in a Hispanic cohort
    Location: Hall F1
    Abstract Poster Presenter: Emmanuel Dominguez-Chapa, MS (he/him/his) – Universidad Autonoma de Nuevo Leon
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2059: Autoantibody Patterns in Myositis Immunoblot Testing: A Retrospective Study inInflammatory Myopathies and Connective Tissue Diseases (2017–2023)
    Location: Hall F1
    Abstract Poster Presenter: Fabricio Benavides, MD – Hospital Universitario Marqués de Valdecilla
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2060: Treatment Patterns And Drug Use In Idiopathic Inflammatory Myopathies. Description Of The First Year After Diagnosis In A Swedish Myositis Cohort.
    Location: Hall F1
    Abstract Poster Presenter: Federico Zazzetti, MD – J&J Innovative Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2061: Tryptophan Metabolism Alteration Is Associated With Rapidly Progressive Interstitial Lung Disease Of Anti-MDA5+ Dermatomyositis
    Location: Hall F1
    Abstract Poster Presenter: Hongjiang Liu, n/a – West China Hospital, Sichuan University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2062: Immune Cell Signatures Associated with Disease Activity in Dermatomyositis Across Autoantibody Subtypes
    Location: Hall F1
    Abstract Poster Presenter: Jeffrey Sagun, BS – Stanford University School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2063: Linking PROMIS scores to disease severity and treatment in dermatomyositis: a patient-centered evaluation
    Location: Hall F1
    Abstract Poster Presenter: Julie Paik, MD, MHS – Johns Hopkins University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2064: Kinematics Underlying IBM-induced Dysphagia
    Location: Hall F1
    Abstract Poster Presenter: Kevin Renz Ambrocio, MS – University of Pittsburgh
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2065: Pain in Idiopathic Inflammatory Myopathies: A Global Study of Patient Experience
    Location: Hall F1
    Abstract Poster Presenter: Lekshmi Minikumari Rahulan, MD, MBBS – Sanjay Gandhi Postgraduate Institute of Medical Sciences
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2066: Psychosocial Factors Strongly Influence Subjective Well-being in Patients with Idiopathic Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: Meera Shah, MD, MBBS – Topiwala National Medical College and Dr. B.Y.L Nair Charitable Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2067: Patterns of Comorbidity in Idiopathic Inflammatory Myopathies: A Cross-sectional Analysis of Disease Burden and Risk Factors
    Location: Hall F1
    Abstract Poster Presenter: Meera Shah, MD, MBBS – Topiwala National Medical College and Dr. B.Y.L Nair Charitable Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2068: Comparing characteristics, diagnostics, and treatment in people with different idiopathic inflammatory myopathies using a large representative cohort
    Location: Hall F1
    Abstract Poster Presenter: Michael George, MD, MSc – University of Pennsylvania
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2069: Concordance of low titer positive myositis-specific autoantibodies and myositis-associated autoantibodies on subsequent myositis panel testing.
    Location: Hall F1
    Abstract Poster Presenter: Nikola Wilk, MD, FRCPC (he/him/his) – University of Ottawa
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2070: Characterization of Hospitalization, Patient Demographics and Impact of Idiopathic Inflammatory Myopathies on Hospitalization Outcomes in Adult Fracture Patients: A National Inpatient Sample Analysis.
    Location: Hall F1
    Abstract Poster Presenter: Pranathi Bandarupalli, MD (she/her/hers) – Mercy St Vincent Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2071: Impact of Diagnostic Delay on Disease Activity and Cumulative Damage in Patients with Idiopathic Inflammatory Myopathies in a Third-level Hospital in Mexico
    Location: Hall F1
    Abstract Poster Presenter: Rebeca Polina-Lugo, MD (she/her/hers) – Division of Rheumatology, Hospital Universitario, UANL
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2072: Results of an Integrated Program for Early Cancer Detection in Idiopathic Inflammatory Myopathies
    Location: Hall F1
    Abstract Poster Presenter: Rebeca Polina-Lugo, MD (she/her/hers) – Division of Rheumatology, Hospital Universitario, UANL
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2073: Cell-free DNA as a Potential Marker of Muscle Involvement and Treatment Response in Myositis
    Location: Hall F1
    Abstract Poster Presenter: Sabína Oreská, MD, PhD (she/her/hers) – Institute of Rheumatology
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2074: Increased Mortality in Hispanic Males with Lymphopenia: A Descriptive and Statistical Analysis of Anti-Melanoma Differentiation-Associated Protein 5 (MDA-5) Antibody Positive Patients
    Location: Hall F1
    Abstract Poster Presenter: Sergio M. Maldonado Chaar, MD (he/him/his) – University of Miami/Jackson Health
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2075: Ferritin trends differentiate anti-MDA5 Dermatomyositis from anti-Jo1 Antisynthetase Syndrome
    Location: Hall F1
    Abstract Poster Presenter: Silvia Grazzini, MD – University of Siena
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2076: Nutritional Discourse in Online Myositis Communities: A Reddit Analysis of Patient-led Discussions
    Location: Hall F1
    Abstract Poster Presenter: Taanya Talreja, MBBS – Seth GS Medical College and KEM Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2077: Statin-Associated Immune-Mediated Necrotizing Myopathy in Native Americans
    Location: Hall F1
    Abstract Poster Presenter: Tam Dinh, MD – University of New Mexico Internal Medicine Program
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2078: Neutrophil Extracellular Traps from Patients with Idiopathic Inflammatory Myopathies Induce Interferogenic Responses in Macrophages and Myeloid Dendritic Cells
    Location: Hall F1
    Abstract Poster Presenter: Yatzil Reyna-Juárez, MD – Instituto Politécnico Nacional
  • Wednesday, Oct 29th
    11:30 AM - 1:00 PM Central Time
    29W18: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science I: Diagnostics & Therapeutics
    Location: W192A-C
    Abstract Moderator: Jisna Paul, MD – Ohio State University Hospital
    Abstract Moderator: Soumya Chatterjee, MD, MS, FRCP, FACP, FACR – Cleveland Clinic
     CE: 0.00
  • Wednesday, Oct 29th
    11:30 AM - 11:45 AM Central Time
    2669: RESET-Myositis: Clinical Trial Evaluating Rese-cel (Resecabtagene Autoleucel), A Fully Human, Autologous 4-1BB CD19-CAR T Cell Therapy in Idiopathic Inflammatory Myopathies
    Location: W192A-C
    Presenting Author: Erin Wilfong, MD, PhD – Vanderbilt University Medical Center
  • Wednesday, Oct 29th
    11:45 AM - 12:00 PM Central Time
    2670: Real-World Experience of Anifrolumab in 24 Patients with Refractory Dermatomyositis: A Multicenter Retrospective Study.
    Location: W192A-C
    Presenting Author: Miriam Retuerto Guerrero, MD – Complejo Asistencial Universitario de León
  • Wednesday, Oct 29th
    12:00 PM - 12:15 PM Central Time
    2671: Effect of Efgartigimod PH20 SC on Total Improvement Score, its Core Set Measures, and Patient/Clinician Impressions of Change: Results from the Phase 2 ALKIVIA Study of Adults with Active Idiopathic Inflammatory Myopathy
    Location: W192A-C
    Presenting Author: Rohit Aggarwal, MD, MS – University of Pittsburgh
  • Wednesday, Oct 29th
    12:15 PM - 12:30 PM Central Time
    2672: Safety and efficacy of Upadacitinib in melanoma differentiation-associated gene 5-positive dermatomyositis with interstitial lung disease: a single-centre, retrospective, propensity score-matched cohort study
    Location: W192A-C
    Presenting Author: Qiong Fu, MD (she/her/hers) – Renji Hospital
  • Wednesday, Oct 29th
    12:30 PM - 12:45 PM Central Time
    2673: Quantitative 18F-FDG PET/CT analysis reveals new patterns of muscle involvement and prognostic indicators in idiopathic inflammatory myopathies: beyond proximal muscle weakness
    Location: W192A-C
    Presenting Author: Fatma Basibuyuk, MD (she/her/hers) – Dokuz Eylül University
  • Wednesday, Oct 29th
    12:45 PM - 1:00 PM Central Time
    2674: Pulmonary ultrasound findings and their relationship with clinical characteristics and myopathy antibodies in a cohort of patients with myositis
    Location: W192A-C
    Presenting Author: Ana Mora-Rosas, Sr, MD (she/her/hers) – Instituto Nacional de Rehabilitación